FIELD: medicine; pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, pharmacology and chemical-pharmaceutical industry. Disclosed are a composition for treating and preventing respiratory diseases containing 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid and N,N'-bis-[2-(1H-imidazol-4-yl)ethyl]pentane diamide, and/or their optical isomers, and/or their pharmaceutically acceptable salts, a pharmaceutical composition based on said compositions, a medicinal agent based on said composition or composition, a ready dosage form based thereon, using said composition, a pharmaceutical composition, a drug or a ready dosage form for treating and preventing respiratory diseases (versions).
EFFECT: technical result: N,N'-bis-[2-(1H-imidazol-4-yl)ethyl]pentane diamide increased stability of 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid under conditions of accelerated aging for 45 days.
18 cl, 4 tbl
